UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 9, 2007
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 0-26224 | 51-0317849 | ||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 311 Enterprise Drive Plainsboro, NJ |
08536 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (609) 275-0500
| Not Applicable |
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On May 9, 2007, Integra LifeSciences Holdings Corporation posted to the “Investor Relations” portion of its website
(www.Integra-LS.com) presentations that included adjusted net income and adjusted diluted earnings per share
for prior periods as well as a reconciliation of these measures to GAAP net income and GAAP earnings per diluted share.
A copy of the material relating to adjusted net income and adjusted diluted earnings per share is attached as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item.
The information contained in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information contained in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit Number
|
Description of Exhibit | |
99.1
|
Selected Information from Website Presentations |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Date: May 9, 2007
By: /s/ Stuart M. Essig
Stuart M. Essig
President and Chief Executive Officer
Exhibit Index
Exhibit Number
|
Description of Exhibit | |
99.1
|
Selected Information from Website Presentations |
Exhibit 99.1
| RECONCILIATION OF REPORTED GAAP EARNINGS PER DILUTED SHARE TO ADJUSTED EARNINGS PER DILUTED SHARE (Q1 06 - Q4 06) |
| A reconciliation of reported GAAP EPS to Adjusted Diluted EPS is provided at the end of this presentation The adjusted diluted earnings per share amounts presented above for Q1 -Q4 2006 are different from those previously reported, as prior amounts were adjusted for the effects of FAS 123R. ADJUSTED DILUTED EARNINGS PER SHARE (Q1 05 - Q1 07) Q1 05 Q2 05 Q3 05 Q4 05 Q1 06 Q2 06 Q3 06 Q4 06 Q1 07 Adjusted Fully Taxed EPS 0.27 0.29 0.36 0.37 0.308 0.35 0.36 0.42 0.33 * * * * *Prior to the adoption of FAS 123R. |
| The adjusted diluted earnings per share amounts presented above for Q1 -Q4 2006 are different from those previously reported, as prior amounts were adjusted for the effects of FAS 123R. A description and discussion of the purpose and uses for Adjusted Diluted EPS is provided in Integra's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 9, 2007. This Current Report on Form 8-K is available on the "SEC Filings" page of the Investor Relations Section of our website at www.Integra-LS.com. A reconciliation of reported GAAP EPS to Adjusted Diluted EPS is available in the Quarterly Financial Summary presentation on the "Presentations and Webcasts" page of the Investor Relations section of our website. Adjusted Diluted Earnings Per Share 17% 26% 38% 23% 14% 19% -1% 12% 7% Q1 05 Q2 05 Q3 05 Q4 05 Q1 06 Q2 06 Q3 06 Q4 06 Q1 07 Adjusted Fully Taxed EPS 0.27 0.29 0.36 0.37 0.308 0.35 0.36 0.42 0.33 Year over Year Growth * * * * *Prior to the adoption of FAS 123R. |